ARCA Biopharma: An Undervalued Biotech With A Bright Future (ABIO)
On February 3, 2014, ARCA filed an 8-K with the SEC disclosing a public offering for 5,116,228 shares of common stock and warrants to purchase an aggregate of 1,279,057 shares of common stock at a purchase price of $1.70 per share. Net proceeds were …
After subscribing to the service (All Levels) this menu will become active to direct you to member database locations and weekly audio recordings. Please refresh the page if you have subscribed and are still seeing this message.